Literature DB >> 7426952

Factors influencing the outcome of vasectomy reversal.

H A Bagshaw, J R Masters, J P Pryor.   

Abstract

Fifty-six vasectomy reversals performed during the period 1976 to 1978 have been reviewed with reference to factors which might influence the outcome. Spermatozoa appeared in the ejaculate in 51 (91%) and remained in numbers greater than 10 million per ejaculate in 35 (63%). The wives of 14 men conceived. The following factors have been shown to be associated with a favourable result: a short delay between vasectomy and its reversal, a short previously resected segment, opalescent fluid from the cut lower end of the vas and the absence of circulating antisperm antibodies. A substantially higher conception rate was achieved when the husband had remained with his original partner. Sixty-two testicular biopsies obtained at the time of vasectomy reversal were examined by light microscopy and showed no gross impairment of spermatogenesis. Immunofluorescent techniques failed to show the presence of antigen antibody complexes in 36 testicular biopsies and in 12 vasal stumps.

Entities:  

Keywords:  Antibodies; Autoimmune Response; Biology; Evaluation; Examinations And Diagnoses; Family Planning; Hematological Effects; Hemic System; Histology; Immunity; Immunoglobulin Alterations; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Male Sterilization; Male Urologic Surgery; Physiology; Reproduction; Research Methodology; Retrospective Studies; Reversibility; Reversible Sterilization; Sperm Count; Spermatogenesis; Sterilization Reversal; Sterilization, Sexual; Studies; Surgery; Treatment; Urogenital Surgery; Vas Reanastomosis

Mesh:

Substances:

Year:  1980        PMID: 7426952     DOI: 10.1111/j.1464-410x.1980.tb02920.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  1 in total

1.  Factors affecting successful outcome from ICSI in men following previous vasectomy.

Authors:  Stephen J Bromage; Jamie Douglas; Debbie A Falconer; Brian A Lieberman; Stephen R Payne
Journal:  World J Urol       Date:  2007-07-03       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.